2023 ACR/CHEST指南：系统性自身免疫性风湿病患者间质性肺病的治疗

2024-07-08 美国风湿病学会 Arthritis Care Res (Hoboken) 发表于上海

本文主要针对SARDs患者ILD的治疗提供指导建议，主要针对针对SARD-ILD的一线治疗、一线ILD治疗后SARD-ILD进展的治疗以及快速进展的ILD治疗提出了35条建议。

中文标题：

英文标题：

2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases

发布机构：

美国风湿病学会

发布日期：

2024-07-08

简要介绍：

间质性肺病（ILD）是系统性自身免疫性风湿病（SARDs）患者发病和死亡的重要原因。本文主要针对SARDs患者ILD的治疗提供指导建议，主要针对针对SARD-ILD的一线治疗、一线ILD治疗后SARD-ILD进展的治疗以及快速进展的ILD治疗提出了35条建议。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=6b3401c00383824c, title=2023 ACR/CHEST指南：系统性自身免疫性风湿病患者间质性肺病的治疗, enTitle=2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases, guiderFrom=Arthritis Care Res (Hoboken), authorId=0, author=, summary=本文主要针对SARDs患者ILD的治疗提供指导建议，主要针对针对SARD-ILD的一线治疗、一线ILD治疗后SARD-ILD进展的治疗以及快速进展的ILD治疗提出了35条建议。, cover=https://img.medsci.cn/20240709/1720504732320_8538692.png, journalId=0, articlesId=null, associationId=528, associationName=美国风湿病学会, associationIntro=The American College of Rheumatology's mission is advancing rheumatology. The organization is for physicians, health professionals, and scientists that meets the mission through programs of education, research, advocacy and practice support. The ACR provides professional education for its members through several venues. The Annual Scientific Meeting, held each fall, is the premier scientific meeting devoted to the rheumatic diseases. This meeting draws thousands of rheumatologists and arthritis health professionals from around the world. A winter rheumatology symposium, spring clinical meetings, and other topical conferences round out the ACR's educational offerings., copyright=0, guiderPublishedTime=Mon Jul 08 00:00:00 CST 2024, originalUrl=, linkOutUrl=, content=<div class="guideDetailsCont flex-row-between-start" style="color: #333333;"> <div class="detailsContRight summary" style="color: #222222;" data-lines="12"><span class="text">间质性肺病（ILD）是系统性自身免疫性风湿病（SARDs）患者发病和死亡的重要原因。本文主要针对SARDs患者ILD的治疗提供指导建议，主要针对针对SARD-ILD的一线治疗、一线ILD治疗后SARD-ILD进展的治疗以及快速进展的ILD治疗提出了35条建议。</span></div> </div>, tagList=[TagDto(tagId=1845, tagName=间质性肺病)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=15, categoryName=风湿免疫, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100)], articleKeywordId=1845, articleKeyword=间质性肺病, articleKeywordNum=6, guiderKeywordId=1845, guiderKeyword=间质性肺病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5128, appHits=26, showAppHits=0, pcHits=310, showPcHits=5089, likes=0, shares=1, comments=0, approvalStatus=1, publishedTime=Fri Jul 12 15:19:00 CST 2024, publishedTimeString=2024-07-08, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Wed Jul 10 21:05:03 CST 2024, updatedBy=8538692, updatedName=梅斯话题小助手, updatedTime=Thu Jul 11 09:25:19 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=上海, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2023+ACR／CHEST指南：系统性自身免疫性风湿病患者间质性肺疾病的治疗.pdf)])

2023+ACR／CHEST指南：系统性自身免疫性风湿病患者间质性肺疾病的治疗.pdf

下载请点击：

评论区 (0)

#插入话题

插入图片

下载梅斯医学APP，方便讨论，随时阅读！立即前往下载 >>

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

呼吸指南

2023 ACR/CHEST指南：系统性自身免疫性风湿病患者间质性肺病的治疗

相关指南

拓展阅读

科室

工具

服务